Centre amends Drugs Rules, 1945 to ensure uniform regulation of advance cell and gene therapies
The Indian government has amended the Drugs Rules, 1945, to bring advanced medical technologies like stem cell therapies, gene-editing products, and xenografts under the Centrally Licence Approving Authority. This move aims to standardize regulatory oversight for complex, emerging medical treatments.
Why it matters
Enhanced regulation for advanced therapies is critical for ensuring patient safety as these complex medical technologies become more prevalent in clinical settings.
Aimed at strengthening regulatory oversight of advanced and emerging medical technologies, the Central government has amended the Drugs Rules, 1945 to bring stem cell derived products, gene therapeutic products, and xenografts under the ambit of the Centrally Licence Approving Authority (CLAA) framework.
The article provides a factual summary of a government regulatory amendment and its stated purpose.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in